Cargando…

Localization of Microfibrillar-Associated Protein 4 (MFAP4) in Human Tissues: Clinical Evaluation of Serum MFAP4 and Its Association with Various Cardiovascular Conditions

Microfibrillar-associated protein 4 (MFAP4) is located in the extracellular matrix (ECM). We sought to identify tissues with high levels of MFAP4 mRNA and MFAP4 protein expression. Moreover, we aimed to evaluate the significance of MFAP4 as a marker of cardiovascular disease (CVD) and to correlate M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wulf-Johansson, Helle, Lock Johansson, Sofie, Schlosser, Anders, Trommelholt Holm, Anne, Melholt Rasmussen, Lars, Mickley, Hans, Diederichsen, Axel C. P., Munkholm, Henrik, Poulsen, Tina Svenstrup, Tornøe, Ida, Nielsen, Vicki, Marcussen, Niels, Vestbo, Jørgen, Sækmose, Susanne Gjørup, Holmskov, Uffe, Sorensen, Grith Lykke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862580/ https://www.ncbi.nlm.nih.gov/pubmed/24349233 http://dx.doi.org/10.1371/journal.pone.0082243

Ejemplares similares

Enzyme-Linked Immunosorbent Assay Characterization of Basal Variation and Heritability of Systemic Microfibrillar-Associated Protein 4
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2013)

Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients
por: Johansson, Sofie Lock, et al.
Publicado: (2019)

Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients
por: Kanaan, Reine, et al.
Publicado: (2023)

Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2015)

Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis
por: Torp, Nikolaj, et al.
Publicado: (2021)

Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients
por: Bracht, Thilo, et al.
Publicado: (2016)

Corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
por: Torp, Nikolaj, et al.
Publicado: (2021)

Circadian, Week-to-Week, and Physical Exercise-Induced Variation of Serum Microfibrillar-Associated Protein 4
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2021)

Microfibril-associated glycoprotein 4 (Mfap4) regulates haematopoiesis in zebrafish
por: Ong, Sheena L. M., et al.
Publicado: (2020)

Pan-Cancer Analysis of Microfibrillar-Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification
por: Qiu, Zhilei, et al.
Publicado: (2022)

MFAP4-Mediated Effects in Elastic Fiber Homeostasis, Integrin Signaling and Cancer, and Its Role in Teleost Fish
por: Mohammadi, Ali, et al.
Publicado: (2022)

Human Microfibrillar-Associated Protein 4 (MFAP4) Gene Promoter: A TATA-Less Promoter That Is Regulated by Retinol and Coenzyme Q10 in Human Fibroblast Cells
por: Lin, Ying-Ju, et al.
Publicado: (2020)

MFAP4 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Through Regulation of Macrophage Infiltration and Activity
por: Pilecki, Bartosz, et al.
Publicado: (2021)

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
por: Mölleken, Christian, et al.
Publicado: (2019)

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4
por: Madsen, Bjørn S., et al.
Publicado: (2020)

MFAP2 is overexpressed in gastric cancer and promotes motility via the MFAP2/integrin α5β1/FAK/ERK pathway
por: Yao, Li-wen, et al.
Publicado: (2020)

Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment
por: Iakovleva, Viktoriia, et al.
Publicado: (2023)

Microfibrillar-associated protein 4 variation in symptomatic peripheral artery disease
por: Hemstra, Line Ea, et al.
Publicado: (2018)

The spliceosome-associated protein Mfap1 binds to VCP in Drosophila
por: Rode, Sandra, et al.
Publicado: (2017)

Molecular Characteristics and Prognostic Role of MFAP2 in Stomach Adenocarcinoma
por: Tang, Fenfen, et al.
Publicado: (2022)

MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy: MFAP2 and autophagy-induced OSCC progression
por: Zhang, Hao, et al.
Publicado: (2023)

MFAP2 enhances cisplatin resistance in gastric cancer cells by regulating autophagy
por: Li, Meng, et al.
Publicado: (2023)

The Macrophage-Specific Promoter mfap4 Allows Live, Long-Term Analysis of Macrophage Behavior during Mycobacterial Infection in Zebrafish
por: Walton, Eric M., et al.
Publicado: (2015)

MFAP5 promotes basal-like breast cancer progression by activating the EMT program
por: Wu, Yanmei, et al.
Publicado: (2019)

MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway
por: Li, Jian-Hui, et al.
Publicado: (2019)

Microfibrillar‐associated protein 4 in serum is associated with asthma in Danish adolescents and young adults
por: Hoffmann‐Petersen, Benjamin, et al.
Publicado: (2019)

Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease
por: Lock-Johansson, Sofie, et al.
Publicado: (2014)

The Caenorhabditis elegans Gene mfap-1 Encodes a Nuclear Protein That Affects Alternative Splicing
por: Ma, Long, et al.
Publicado: (2012)

Human MFAP1 is a cryptic ortholog of the Saccharomyces cerevisiae Spp381 splicing factor
por: Ulrich, Alexander K. C., et al.
Publicado: (2017)

MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer
por: Dong, Si Yang, et al.
Publicado: (2020)

MFAP2 Promotes the Proliferation of Cancer Cells and Is Associated With a Poor Prognosis in Hepatocellular Carcinoma
por: Zhu, Xiang, et al.
Publicado: (2020)

Depletion of the MFAP1/SPP381 Splicing Factor Causes R-Loop-Independent Genome Instability
por: Salas-Armenteros, Irene, et al.
Publicado: (2019)

MFAP2 promotes HSCs activation through FBN1/TGF‐β/Smad3 pathway
por: Sun, Yonghong, et al.
Publicado: (2023)

A thymus-specific noncoding RNA, Thy-ncR1, is a cytoplasmic riboregulator of MFAP4 mRNA in immature T-cell lines
por: Aoki, Kazuma, et al.
Publicado: (2010)

High Expression Levels of AGGF1 and MFAP4 Predict Primary Platinum-Based Chemoresistance and are Associated with Adverse Prognosis in Patients with Serous Ovarian Cancer
por: Zhao, Haiyue, et al.
Publicado: (2019)

A Variant Form of the Human Deleted in Malignant Brain Tumor 1 (DMBT1) Gene Shows Increased Expression in Inflammatory Bowel Diseases and Interacts with Dimeric Trefoil Factor 3 (TFF3)
por: Madsen, Jens, et al.
Publicado: (2013)

lncRNA LCPAT1 Upregulation Promotes Breast Cancer Progression via Enhancing MFAP2 Transcription
por: Gong, Xue, et al.
Publicado: (2020)

lncRNA LCPAT1 Upregulation Promotes Breast Cancer Progression via Enhancing MFAP2 Transcription
por: Gong, Xue, et al.
Publicado: (2022)

DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma
por: Ke, Yumin, et al.
Publicado: (2022)

MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3
por: Xue, Meng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ik4q566t7rh2vmrd6egknbc6t5